T. Rowe Price Investment Management, Inc. Immunocore Holdings PLC Call Options Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
124Shares Held
35.9MCall Options Held
79.9KPut Options Held
46.2K-
Rtw Investments, LP New York, NY4.87MShares$143 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$78.2 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$64.1 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA1.56MShares$45.6 Million3.45% of portfolio
-
Baker Bros. Advisors LP New York, NY1.52MShares$44.4 Million0.5% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.29B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...